Towards full recovery with lurasidone: effective doses in the treatment of agitation, affective, positive and cognitive symptoms in schizophrenia, and dual psychosis

María Teresa Guarro Carreras, Luis Jiménez Suárez, Laura Lago García, Laura Montes Reula, Adrián Neyra del Rosario, Francisco Acoidan Rodríguez Batista, Miguel Velasco Santos, Juan L Prados-Ojeda, Marina Diaz-Marsà, Manuel Martín-Carrasco, Antonio Cardenas

Article Type

Case Series

Published

This review explores the effectiveness of high doses of lurasidone in managing all schizophrenia symptoms and its role in addressing post-psychotic depression in dual psychosis cases. Additionally, it delves into real-world insights on the clinical application of lurasidone.

Read more

Propranolol for the management of behavioural and psychological symptoms of dementia

Rajesh R Tampi, Deena J Tampi, Syeda Arshiya Farheen, Sochima I Ochije, Pallavi Joshi

Article Type

Review

Published

There is some evidence that propranolol may benefit individuals with behavioural and psychological symptoms of dementia (BPSD). This article discusses three case series that assessed the use of propranolol for the management of BPSD. From these studies, it appears that propranolol improves BPSD and is well tolerated. In clinical practice, the routine use of propranolol among people with BPSD cannot be recommended at this time given the limited data. However, propranolol can be trialled among individuals with BPSD when symptoms have not responded adequately to other medications.

Read more

Prazosin for the management of behavioural and psychological symptoms of dementia

Rajesh R Tampi, Deena J Tampi, Syeda Arshiya Farheen, Mahwish Adnan, Dhweeja Dasarathy

Article Type

Review

Published

The goal of this report is to identify, from a systematic review of the literature, the evidence for using prazosin in the management of behavioural and psychological symptoms of dementia including agitation and aggression from controlled studies.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.